Navigation Links
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013
Date:2/4/2013

nt selection marker for response to ARRY-520.  A related presentation assessing the same group of ARRY-520-treated patients observed that, for patients retrospectively selected with a lower AAG level, the overall response rate (≥PR) increased to 33% (from 22%) with a median time on study of 6.2 months.  The clinical benefit rate (≥MR) was 50% in the selected population. 

Interim data from an ongoing investigator-sponsored combination trial of ARRY-520 with Kyprolis in patients with relapsed or refractory MM who are refractory or intolerant to Velcade® (bortezomib) were also reported at the conference.  The combination has demonstrated early signals of activity, with a 56% clinical benefit rate (≥MR). In addition, it has been well tolerated with limited hematologic toxicity and a manageable side effect profile.

ARRY-614 – FDA meeting provides guidance on primary endpointDuring the quarter, Array continued to evaluate ARRY-614 in an ongoing clinical trial in patients with low or intermediate-1 risk MDS using an optimized formulation. As presented at ASH, this new formulation has demonstrated improved bioavailability and target coverage in this patient population. With this new formulation, peak plasma concentrations and overall exposures are higher than with the original formulation. The ongoing Phase 1 dose escalation trial of the optimized ARRY-614 formulation may further our understanding of the contributions of these targets to the pathogenesis of MDS.  In a prior study in a similar population, up to a 40% response rate for hematologic improvement was observed in patients. 

Array also met with the FDA to discuss the development plan to support registration and received guidance from the FDA on the primary endpoint, including a discussion of endpoints other than overall survival that could be used as the basis for approval.  Array has now defined a potential p
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
2. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
3. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
4. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
5. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
6. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
7. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
8. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
9. John A. Orwin Joins Array BioPharma Board Of Directors
10. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
11. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... (PRWEB) September 23, 2014 Cambridge Semantics, ... Semantic Web technology, was named in the recent ‘Hype ... Inc. , The report details key insights pertaining ... , According to Gartner analysts Michael Shanler and Stephen ... innovation activities, expose complex relationships with scientific stakeholders, and ...
(Date:9/23/2014)... WASHINGTON, New York , September 23, 2014 ... ), a leading provider of  Closed System Transfer   ... a new exclusive partnership with Taiwanese distributor MedFront Medical Technology ... regulatory bodies in Taiwan , ... for approval as the company continues to expand ...
(Date:9/23/2014)... Latham, NY (PRWEB) September 23, 2014 ... line of deep ultra violet emitters in the 280 ... of standard UV emitters which range from 280nm to ... air and water sanitation as well as curing. Mark ... product line of special interest to manufacturers is that ...
(Date:9/23/2014)... York (PRWEB) September 23, 2014 ... around the globe will convene at the ... Conference, to be held October 26-28 in ... evidence-based research and practice in individualized integrative ... scientists, researchers, nurses, psychologists, nutritionists, naturopaths, acupuncturists, ...
Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2Marktech Introduces its New Line of Deep UV Emitters 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... Celsion Corporation (Nasdaq: CLSN ), an oncology ... of innovative oncology drugs, today announced that it has ... select group of institutional investors, including certain officers and ... 8% redeemable convertible preferred stock with a stated value ...
... massive death of brain cells after a stroke, the explosion in ... as autism, schizophrenia and mental retardation show no physical signs of ... brain cells communicate with one another. To understand ... activity is key. But even the best imaging devices available ...
... success of the previous conferences of the series held ... (EPD) conferences are a leading venue for experts from ... as a processing technique for fabrication of both traditional ... electric surface charge on particles in suspension, which migrate ...
Cached Biology Technology:Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 2Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 3Celsion Corporation Announces Convertible Preferred Stock Financing and Amended License Agreement for Aggregate Gross Proceeds of up to $9 Million 4New UCLA-designed microscope records firing of thousands of individual neurons in 3-D 2New UCLA-designed microscope records firing of thousands of individual neurons in 3-D 34th International Conference on Electrophoretic Deposition 24th International Conference on Electrophoretic Deposition 34th International Conference on Electrophoretic Deposition 4
(Date:9/22/2014)... be much more useful in homes, if they could ... the world with cameras and lasers, which have difficulty ... hidden in clutter. A complementary way robots can "sense" ... small ultra-high frequency radio-frequency identification (UHF RFID) tags. Inexpensive ... RFID-equipped robot to search a room for the correct ...
(Date:9/22/2014)... -- NXT-ID, Inc. (NASDAQ: NXTD ), a ... market, issues the following corporate shareholder update following the ... Letter from the CEO : ... joined the NASDAQ to support ramping of production of ... authentication products and services. This strategic achievement positions NXT-ID to ...
(Date:9/21/2014)... cowpea (black-eyed peas) is a fascinating example of how ... is the story of the scientist behind the research. ... of the 21st Century to serve as an accessible ... was recently published by the Crop Science Society of ... (IITA). , Singh has devoted his life,s work to ...
Breaking Biology News(10 mins):New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3NXT-ID Issues Shareholder Corporate Update 2NXT-ID Issues Shareholder Corporate Update 3NXT-ID Issues Shareholder Corporate Update 4
... examine the safety and preliminary effectiveness of two ... opened to volunteer enrollment. The trial, sponsored by ... (NIAID), part of the National Institutes of Health, ... Africa and the United States. , Although no ...
... "Because up to 75 percent of breast cancer,patients ... pathway,drugs that target different molecules along that pathway ... a researcher from,The University of Texas M. D. ... now emerging,about the importance of the phosphatidylinositol 3 ...
... PANTHER, a protein classification system from,Applied Biosystems, got ... molecular and biological function (GO ontology) and known,pathways. ... it incorporate,automated GO surrepresentation analysis with graphical output. ... paper describing the Database is available freely ...
Cached Biology News: MetaChip provides quick, efficient toxicity screening of potential drugs 2PANTHER Protein Classification System Database 5.0 2PANTHER Protein Classification System Database 5.0 3
... V is a fully integrated system for ... processing that deliver excellent quality microarray images. ... quality microarray scanner that is based on ... background rejection and spatial resolution. The DNAscope ...
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Rabbit polyclonal antibody to NCOA2 [Agarose Immobilized]...
Monocarboxylate (lactate) transporter 2...
Biology Products: